mRNA manufacturing device
NTX-0565 RD T cell lymphoma; NTX-0470 RD genitourinary tumors
Nutcracker Therapeutics is developing and producing RNA therapeutics as fast as possible using microfluidic technology. RNA therapeutics have many advantages - versatility, speed, efficacy and safety. However, manufacturing has hindered the production of RNA therapeutics for multiple diseases. Through the use of their proprietary Biochip-based manufacturing platform, Nutcracker is using biochemistry, nanoparticle delivery and microfluidic engineering to automate and scale RNA therapeutics. As Nutcracker is focused on the technology, they are partnering with experts in different diseases to bring their products to patients. Currently, Nutcracker has 3 programs close to clinical trials for different cancers.
Staff Engineer, Systems Engineering
Emeryville, CA|19 days ago
Senior Vice President, Technical Operations
Emeryville, CA|79 days ago